Arthneeti

One Global Service Provider Share Price & Earnings Call Analysis

₹444.80-3.72% today
Market cap
₹869 Cr
P/E
11.76
ROE
65.27%
PEG
0.04
Price to sales
1.69
Debt to equity
0.00
52W high / low
₹783 / ₹358
Sales growth (5Y)
167.02%
EBITDA margin
19.21%
Net profit margin
13.95%
Promoter holding
68.40%
Sales (last year)
₹513 Cr

Incorporated in 1992, One Global Service Provider Ltd is in the business of healthcare services[1]

Potential multibaggers · Q2 FY27

Potential multibaggers in Healthcare Services
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Aster DM Quality Care LtdGood growth
    3
See all potential multibaggersWhere does One Global Serv rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Healthcare Services companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹921 Cr—
240%+Flat₹575 Cr21.9
3Aster DM Quality Care Ltd20–40%Up 2%+₹59,405 Cr164.6
420–40%Up 2%+₹551 Cr18.5
520–40%Up 0–2%₹1,635 Cr16.5
620–40%Flat₹1.21L Cr57.7

Sign up free to see every company in the sector ranking and track One Global Serv.

Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services ranking

One Global Serv announcements

All announcements →

Financials of One Global Serv

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of One Global Serv

Quarterly Results

Quarter-by-quarter operating performance

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales +85131215241419335588135141
Expenses +75111113191116294175109112
Operating Profit11112523515132629
OPM %9%10%11%8%14%22%17%16%14%26%15%19%21%
Other Income +0000000000000
Interest0000000000000
Depreciation0000000000000
Profit before tax10112523515132629
Tax %-2%-2%25%25%25%26%25%25%27%25%25%25%25%
Net Profit +10111422311102022
EPS in Rs0.820.621.380.972.055.592.483.204.9015.4813.8210.1311.08

Financials of One Global Serv

Profit & Loss

Annual income statement trend

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales +0000020461863147420
Expenses +0000020151653122337
Operating Profit-0-0-0-000-0212102583
OPM %73%14%68%23%9%15%17%20%
Other Income +0000000000011
Interest0000000000-000
Depreciation0000000000011
Profit before tax-0-0-0-000-0211102583
Tax %0%0%0%0%0%0%0%0%-3%-1%25%26%
Net Profit +-0-0-0-000-021171862
EPS in Rs-0.35-0.14-0.11-0.130.270.38-0.423.281.481.9410.0126.0050.51
Dividend Payout %0%0%0%0%0%0%0%0%0%0%10%0%

Financials of One Global Serv

Balance Sheet

Capital structure and asset base

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital777777777772020
Reserves-4-5-5-5-5-4-5-2-1075282
Borrowings +0000100000000
Other Liabilities +00002101251734124
Total Liabilities3333543681332106226
Fixed Assets +0000000111122
CWIP3333333333300
Investments0000000000000
Other Assets +000021035928104223
Total Assets3333543681332106226

Financials of One Global Serv

Cash Flows

Operating, investing and financing cash movement

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +-0-0-0-0-00-0110114
Cash from Investing Activity +-0000000-1-1-0-0-0
Cash from Financing Activity +00000-000000-1
Net Cash Flow-0-00-0-0000-0-0114
Free Cash Flow-0-0-0-0-00-0-0-0-0114
CFO/OP96%90%162%111%-32%141%6%45%38%8%12%67%

Financials of One Global Serv

Ratios

Working capital efficiency and return ratios

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days3651490242164152134
Inventory Days000000
Days Payable
Cash Conversion Cycle3651490242164152134
Working Capital Days42137149135765759
ROCE %-9%-4%-3%-3%6%9%-11%60%18%20%85%56%
25out of 100

Momentum score · price trend

25 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months+31.8%79%
Last 6 months−15.7%27%
Last 3 months−14.8%32%

The price is 41% below its all-time high of ₹783.35 (16 Feb 2026). Stocks more than 20% below their peak have their score halved, so 49 became 25.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For One Global Serv: 0.4 × 79 + 0.4 × 27 + 0.2 × 32 = 49, halved to 25 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 2 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

Others in Healthcare Services this season

  • Vijaya Diagnostic Centre (Q2 FY27)

    Q2 FY27 Revenue from Operations: INR 2,554 Mn, up 26.7% YoY (Page 10, 9) . Key investor presentation takeaways from Vijaya Diagnostic Centre Ltd's Q2 FY27 inves

  • Shalby (Q2 FY27)

    Consolidated Total Revenue for Q2 FY27: ₹3,182 million vs ₹2,899 million in Q2 FY26, up 9.8% YoY (Pages 5, 6, 8, 9) . Key investor presentation takeaways from S

  • Metropolis Healt (Q2 FY27)

    Q2FY27 revenue from operations: INR 496.8 Cr, up 15.8% YoY (Page 11) . Key investor presentation takeaways from Metropolis Healthcare Ltd's Q2 FY27 investor pre

  • Nephrocare Health Services (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹303.4 Cr, up 23.5% YoY from ₹245.7 Cr in Q2 FY26 (Page 9). Key investor presentation takeaways from Nephrocare Health Services

Compare:vs Apollo Hospitalsvs Max Healthcarevs Manipal Health